MEDICAL FACILITIES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.21 CAD | +2.26% |
|
+4.18% | +35.97% |
| May. 09 | Transcript : Medical Facilities Corporation - Shareholder/Analyst Call | |
| May. 09 | Medical Facilities Q1 Net Income Falls on Slightly Lower Revenue; Dividend Raised | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- With a P/E ratio at 13.72 for the current year and 15.07 for next year, earnings multiples are highly attractive compared with competitors.
- Sales forecast by analysts have been recently revised upwards.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company sustains low margins.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +35.97% | 218M | - | ||
| -23.39% | 15.56B | B+ | ||
| -2.70% | 11.65B | B | ||
| +2.65% | 11.58B | B+ | ||
| +2.37% | 10.06B | B+ | ||
| -10.45% | 7.16B | A- | ||
| +8.05% | 6.85B | B- | ||
| -4.29% | 5.71B | D | ||
| +13.33% | 4.3B | B+ | ||
| -3.96% | 4.3B | - |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- DR Stock
- Ratings Medical Facilities Corporation
